FDA warns Ket Plug that its ketamine websites sell unapproved, misbranded ketamine powder to U.S. consumers.
What happened
FDA reviewed the website www.buyketaminepowderonline.com (which redirects from www.ketaminelab.org) in April 2026, record FEI 3044408515. The site sells ketamine powder and makes claims about brain function, depression and mood research, which FDA says shows the powder is intended as a drug for human use. FDA found no approved drug application for the product and no adequate directions for use on its labeling.
What FDA found
The ketamine powder is a new drug sold without an FDA-approved application, which the law requires.
Section 505(a), FD&C Act (21 U.S.C. 355(a)); section 301(d) (21 U.S.C. 331(d))Website claims about brain function, depression and mood research show the powder is intended to treat or affect the body, so it is a drug.
Section 201(g)(1), FD&C Act (21 U.S.C. 321(g)(1)); 21 CFR 201.128The labeling does not give adequate directions for safe use, and the product is a prescription drug that is not safe for a layperson to use on their own.
Section 502(f)(1), FD&C Act (21 U.S.C. 352(f)(1))Shipping this misbranded drug across state lines is a prohibited act.
Section 301(a), FD&C Act (21 U.S.C. 331(a))
What FDA wants
FDA asks the company to stop offering any unapproved and misbranded drugs for sale to U.S. consumers, and to send a written response with corrective steps and supporting documents to FDAAdvisory@fda.hhs.gov, citing reference MARCS-CMS 728919, within 15 business days.
Who should pay attention
- companies selling 'research use only' powders online
- ketamine clinics and telehealth prescribers
- online sellers of prescription drugs to U.S. consumers
This is a summary. Read the original letter on fda.gov.